N-(2-aryl-propionyl)-sulfonamides and pharmaceutical...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S252120, C514S448000, C514S552000, C514S562000, C514S602000, C514S238200, C544S159000, C544S400000, C549S072000, C558S413000, C562S430000, C564S088000, C564S099000

Reexamination Certificate

active

06887903

ABSTRACT:
The compounds of formula 1wherein R and R2are as defined in the disclosure, are useful in the prevention and treatment of tissue damage due to exacerbated recruitment of polymorphonuclear neutrophils (PMN leukocytes) at the inflammatory sites.

REFERENCES:
patent: 4082707 (1978-04-01), Orzalesi et al.
patent: 5006542 (1991-04-01), Hall et al.
patent: 5633287 (1997-05-01), Lee et al.
patent: 6117909 (2000-09-01), Krause
patent: 6166064 (2000-12-01), Dombrowski et al.
patent: A849256 (1998-06-01), None
Kakeya et al., Tetrahedron Letters, vol. 32, No. 10, pp. 1343-1346 (1991).
Regitz, Chemische Berichte, vol. 98, No. 4, pp. 1210-1224 (1965).
Belletire et al., Tetrahedron Letters, vol. 27, No. 2, pp. 131-134 (1986).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

N-(2-aryl-propionyl)-sulfonamides and pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-(2-aryl-propionyl)-sulfonamides and pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(2-aryl-propionyl)-sulfonamides and pharmaceutical... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3427372

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.